B03
Project Area B - Chemical Biology
Prof. Dr. Stefan Knapp
Pharmaceutical Chemistry
Goethe-University Germany, Frankfurt am Main
Phone: +49 170 3682 052
Email
Development of selective inhibitors and PROTACs for key signalling molecules regulating cell state transition and the cell cycle
Chemical tools, highly potent and selective chemical probes as well as molecules that lead to rapid and selective degradation of target proteins such as PROTACs (PROteolysis TArgeting Chimeras) are therefore versatile tools for cell based or in vivo studies on cell states that allow selective targeting of endogenous proteins in a time controlled manner. Our laboratory has a long standing interest in developing selective chemical tool compounds in particular targeting signalling molecules including protein kinases as well as modulators of epigenetic processes. One of the main contributions to this CRC will be therefore providing chemical probe collections tailored to studies on cell state transitions investigated by CRC groups and to develop new chemical probes and PROTACs for targets of high priority within this CRC. Projects that have been identified in the initial phase of this project comprise tailored probe sets for mitotic kinases and epigenetic modulators such as inhibitors of lysine methyltransferases, lysine deacetylases as well as bromodomains.
Project Members
Martin Schwalm
Janik Weckesser
Publications
-
Design, Synthesis, and Biochemical Evaluation of Novel MLK3 Inhibitors: A Target Hopping ExampleIn: Journal of Medicinal Chemistry, Vol. 68, 2025, Nr. 1, pp. 674 – 694
-
Development and Discovery of a Selective Degrader of Casein Kinases 1 δ/ϵIn: Journal of Medicinal Chemistry, Vol. 68, 2025, Nr. 1, pp. 506 – 530
-
Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein DegradationIn: ACS Chemical Biology, Vol. 20, 2025, Nr. 1, pp. 94 – 104DOI (Open Access)
-
Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profilingIn: SLAS Discovery, Vol. 31, 2025, 100214DOI (Open Access)
-
Workflow for E3 Ligase Ligand Validation for PROTAC DevelopmentIn: ACS Chemical Biology, Vol. 20, 2025, Nr. 2, pp. 507 – 521DOI (Open Access)
-
A chemical probe to modulate human GID4 Pro/N-degron interactionsIn: Nature Chemical Biology, Vol. 20, 2024, Nr. 9, pp. 1164 – 1175
-
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pocketsIn: Nature Communications, Vol. 15, 2024, Nr. 1, 10204DOI (Open Access)
-
Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SNAr ElectrophilesIn: Journal of Medicinal Chemistry, Vol. 67, 2024, Nr. 8, pp. 6549 – 6569
-
Expanding the ligand spaces for E3 ligases for the design of protein degradersIn: Bioorganic and Medicinal Chemistry, Vol. 105, 2024, 117718DOI (Open Access)
-
Luciferase- and HaloTag-based reporter assays to measure small-molecule-induced degradation pathway in living cellsIn: Nature Protocols, Vol. 19, 2024, Nr. 8, pp. 2317 – 2357
-
Splice variants of CK1α and CK1α-like : Comparative analysis of subcellular localization, kinase activity, and function in the Wnt signaling pathwayIn: The Journal of Biological Chemistry (JBC), Vol. 300, 2024, Nr. 7, 107407DOI (Open Access)
-
Toward effective Atg8-based ATTECs : Approaches and perspectivesIn: Journal of Cellular Biochemistry, Vol. 125, 2024, Nr. 11: Special Issue: New Horizons in Selective Autophagy, e30380DOI (Open Access)
-
tracerDB : a crowdsourced fluorescent tracer database for target engagement analysisIn: Nature Communications, Vol. 15, 2024, Nr. 1, 5646DOI (Open Access)
-
Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimizationIn: Cell Chemical Biology, Vol. 30, 2023, Nr. 7, pp. 753 – 765.e8DOI, Online Full Text (Open Access)
-
A Toolbox for the Generation of Chemical Probes for Baculovirus IAP Repeat Containing ProteinsIn: Frontiers in Cell and Developmental Biology, Vol. 10, 2022, 886537DOI (Open Access)
-
Novel, highly potent PROTACs targeting AURORA-A kinaseIn: Current Research in Chemical Biology, Vol. 2, 2022, 100032DOI (Open Access)
-
PROTAC degraders as chemical probes for studying target biology and target validationIn: Chemical Society Reviews, Vol. 51, 2022, Nr. 18, pp. 7971 – 7993
-
Targeted degradation of USP7 in solid cancer cells reveals disparate effects of deubiquitinase inhibition vs. acute protein depletion2025DOI, Online Full Text (Open Access)
-
Inhibitor-induced supercharging of kinase turnover via endogenous proteolytic circuits2024DOI (Open Access)
-
High-Throughput Screening for LC3/GABARAP Binders Utilizing the Fluorescence Polarization AssayIn: Selective Autophagy: Methods and Protocols / Nezis, Ioannis P. (Eds.). New York: Humana Press Inc., 2024, pp. 203 – 218
-
Targeting the Acetylation Reader Family : Bromodomain ProteinsIn: Epigenetic Drug Discovery / Chan, Ho Man; Arrowsmith, Cheryl (Eds.). London: Royal Society of Chemistry, 2024, pp. 404 – 439
-
Thermodynamic Characterization of LC3/GABARAP : Ligand Interactions by Isothermal Titration CalorimetryIn: Selective Autophagy / Nezis, Ioannis P. (Eds.). Totowa, NJ: Humana Press Inc., 2024, pp. 219 – 235